Lc. Wienkers et al., FORMATION OF (R)-8-HYDROXYWARFARIN IN HUMAN LIVER-MICROSOMES - A NEW METABOLIC MARKER FOR THE (S)-MEPHENYTOIN HYDROXYLASE, P4502C19, Drug metabolism and disposition, 24(5), 1996, pp. 610-614
Kinetic studies demonstrate that two forms of human liver cytochrome P
450 are responsible for the formation of (R)-8-hydroxywarfarin: a low-
affinity enzyme (K-M similar to 1.5 mM), previously identified as P450
1A2; and a high-affinity enzyme (K-M = 330 mu M), now identified as P4
502C19 on the basis of the following evidence. In cross-over inhibitio
n studies with P4501A2-depleted human liver microsomes between (R)-war
farin and (S)-mephenytoin, reciprocal competitive inhibition was obser
ved. Apparent K-M values for (S)-mephenytoin-4'-hydroxylation (52-67 m
u M) were similar to the determined K-i values (58-62 mu M) for (S)-me
phenytoin inhibition of (R)-8-hydroxywarfarin formation. Similarly, th
e apparent K-M for (R)-warfarin 8-hydroxylation in furafylline-pretrea
ted microsomes (K-M = 289-395 mu M) was comparable with the K-i values
(280-360 mu M) for (R)-warfarin inhibition of (S)-4'-hydroxymephenyto
in formation. Inhibition studies with tranylcypromine, a known inhibit
or of (S)-mephenytoin hydroxylase activity, acid either substrate in t
hree different microsomal preparations yielded nearly identical inhibi
tory constants: K-i = 8.7 +/- 1.6 mu M for inhibition of (S)-4'-hydrox
ymephenytoin formation and 8.8 +/- 2.5 mu M for inhibition of (R)-8-hy
droxywarfarin formation. In addition, fluconazole, a potent inhibitor
of (R)-warfarin 8-hydroxylation, K-i = 2 mu M, was found to Inhibit (S
)-mephenytoin hydroxylation with an identical K-i (2 mu M). Finally, a
strong correlation between (S)-mephenytoin 4-hydroxylation and (R)-wa
rfarin 8-hydroxylation activities in furafylline-pretreated microsomes
was demonstrated in 14 human liver microsomal preparations (r(2) = 0.
97).